Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Prepaid Assets: 2023-2025

Historic Prepaid Assets for Artiva Biotherapeutics (ARTV) over the last 2 years, with Sep 2025 value amounting to $6.5 million.

  • Artiva Biotherapeutics' Prepaid Assets rose 100.34% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 100.34%. This contributed to the annual value of $3.1 million for FY2024, which is 179.95% up from last year.
  • Latest data reveals that Artiva Biotherapeutics reported Prepaid Assets of $6.5 million as of Q3 2025, which was down 2.91% from $6.7 million recorded in Q2 2025.
  • Over the past 5 years, Artiva Biotherapeutics' Prepaid Assets peaked at $6.7 million during Q2 2025, and registered a low of $1.1 million during Q4 2023.
  • In the last 3 years, Artiva Biotherapeutics' Prepaid Assets had a median value of $3.2 million in 2024 and averaged $3.7 million.
  • Data for Artiva Biotherapeutics' Prepaid Assets shows a peak YoY spiked of 285.16% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Artiva Biotherapeutics' Prepaid Assets stood at $1.1 million in 2023, then skyrocketed by 179.95% to $3.1 million in 2024, then spiked by 100.34% to $6.5 million in 2025.
  • Its last three reported values are $6.5 million in Q3 2025, $6.7 million for Q2 2025, and $3.8 million during Q1 2025.